NCT04785703

Brief Summary

Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 22, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 8, 2021

Completed
Last Updated

March 8, 2021

Status Verified

March 1, 2021

Enrollment Period

2 months

First QC Date

March 3, 2021

Last Update Submit

March 3, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • prolactin receptors expression in oral mucous membrane

    immuno-histochemistry

    24 hours

Study Arms (1)

oral lichen planus group

patients with chronic bollus erosive lichen planus

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Egyptian patients with OLP

You may qualify if:

  • patients with oral lichen planus
  • systemically healthy

You may not qualify if:

  • oral lichenoid lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

October University for modern sciences and arts

Giza, Egypt

Location

MeSH Terms

Conditions

Lichen Planus, Oral

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic DiseasesLichen PlanusLichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

March 3, 2021

First Posted

March 8, 2021

Study Start

June 19, 2020

Primary Completion

August 22, 2020

Study Completion

December 10, 2020

Last Updated

March 8, 2021

Record last verified: 2021-03

Locations